Brief: Windtree Therapeutics Reports Q3 Results, Provides Key Business Updates
14/11/2022 17:14
Nov 14 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES KEY BUSINESS UPDATES
* QTRLY NET LOSS PER COMMON SHARE BASIC AND DILUTED $0.13
* AS OF SEPTEMBER 30, 2022, COMPANY REPORTED CASH AND CASH
EQUIVALENTS OF $8.4 MILLION
Source text for Eikon: ID:nGNX5wmtml
Further company coverage: WINT.O
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study